Marker Therapeutics MRKR
NASDAQ MRKR
$1.07 -0.06 (-5.31%)
At close: Oct 22, 2026 · 4:00 PM EDT

Marker Therapeutics (MRKR) Treasury Shares (2011)

Updated

Marker Therapeutics (MRKR) recorded Treasury Shares of 586,858 in Q2 2011.

Analysis

Marker Therapeutics (MRKR) Treasury Shares (2011) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Treasury Shares (Qtr)
1 Eli Lilly 1,230.11 Bn 1,198.70 Bn 19.71 Bn -
2 Johnson & Johnson 644.39 Bn 564.25 Bn 17.30 Bn 712.73 Mn
3 AbbVie 503.52 Bn 476.68 Bn 12.70 Bn 77.11 Mn
4 Merck 363.29 Bn 317.72 Bn 12.21 Bn 1.11 Bn
5 Novartis Ag 298.23 Bn 262.62 Bn 11.24 Bn 49.00 Mn
6 Astrazeneca 267.53 Bn 241.29 Bn 12.86 Bn -
7 Amgen 241.80 Bn 197.20 Bn 7.24 Bn -
8 Gilead Sciences 195.07 Bn 169.19 Bn 6.22 Bn -
9 Pfizer 173.33 Bn 120.28 Bn 10.94 Bn 3.94 Bn
10 Marker Therapeutics 17.87 Mn -42.04 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2011 586,858.00
API Access

Marker Therapeutics Treasury Shares API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=treasury-shares&ticker=MRKR&period=max&api_key=YOUR_API_KEY